Photo of Kris Kappel

Kris enjoys the fast pace of the ever-changing life sciences industry in which she focuses her intellectual property (IP) and technology licensing practice.

As co-chair of the firm’s Intellectual Property and Life Sciences teams, Kris counsels clients on how to manage and protect their intellectual property and data and use their IP assets strategically. Kris drafts and negotiates complex agreements related to technology and software licensing, software and web development, joint development and confidentiality. She often negotiates these agreements for healthcare, higher education and biofuel clients.

Recently, I was at a technology fair with my young son and there were multiple desktop 3D printers that were on display and for sale. One display that caught my eye showed 16 printers stacked together with each one in a different stage of printing. Several of the printers were printing figures of dragons and dinosaurs. My son thought they looked like fun and asked for one for his birthday. I asked him what he would use it for and he said that he would want to print out dinosaur figures, action figures, ships from Star Wars® or missing Lego® pieces. He said that he could make his toys exactly how he wanted his toys to look.

This got me thinking and I wondered if he could actually do it, print toys and figures that are protected by copyrights. Wouldn’t it be great if you could just print that missing Monopoly® piece?

3D printing continues to transform the medical field. Recently, doctors in Spain produced the world’s first 3D-printed rib cage and sternum, which is made entirely of titanium. The doctors surgically implanted the metal rib cage and sternum in a cancer patient. Last month, the FDA approved the first 3D-printed drug. The drug, which Aprecia Pharmaceuticals has named Spritam, is for treating patients with epilepsy. Aprecia Pharmaceuticals’ ZipDose® Technology utilizes 3D printing that overlays multiple layers of powdered medication on top of one another until the correct dosage is reached. This type of technology can lead to easier-to-take medication that is individualized in nature with precise dosages based on a patient’s needs.